ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,111Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1000

$1.02M Total Retail Price of All Prescriptions

Rank: 47 out of 1000

988 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 988 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 988 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 17,505 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
OMEPRAZOLE 951 756 1 2
SIMVASTATIN 755 630 2 3
HYDROCODONE-ACETAMINOPHEN 675 406 S3 3 1
LEVOTHYROXINE SODIUM 655 545 4 4
AMLODIPINE BESYLATE 557 448 5 6
METFORMIN HCL 488 338 6 8
TRAMADOL HCL 473 344 7 13
CARVEDILOL 467 398 8 15
CITALOPRAM HBR 462 349 9 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 429 354 10 20
LISINOPRIL 368 296 11 5
GLIMEPIRIDE 366 278 12 34
GABAPENTIN 360 263 13 11
FUROSEMIDE 317 295 14 7
POTASSIUM CHLORIDE 307 267 15 10
METOPROLOL SUCCINATE 284 211 16 21
TRAZODONE HCL 280 193 17 29
HYDROCHLOROTHIAZIDE 276 191 18 9
WARFARIN SODIUM 247 205 19 22
CEFUROXIME 247 179 19 133
ZOLPIDEM TARTRATE 239 158 21 16
NEXIUM 219 185 22 23
LEVOFLOXACIN 212 170 23 73
PRAVASTATIN SODIUM 200 160 24 12
METHYLPREDNISOLONE 199 158 25 103
RANITIDINE HCL 199 135 25 37
ATORVASTATIN CALCIUM 192 178 27 18
FLUOXETINE HCL 188 90 28 51
BACLOFEN 183 124 29 129
CYMBALTA 178 106 30 53
CRESTOR 177 133 31 30
CLOPIDOGREL 177 160 31 35
METOPROLOL TARTRATE 177 168 31 19
DONEPEZIL HCL 177 155 31 32
ENALAPRIL MALEATE 169 125 35 58
PAROXETINE HCL 168 105 36 63
TRIAMTERENE-HCTZ 165 132 37 48
ALLOPURINOL 161 127 38 31
SERTRALINE HCL 155 89 39 26
LOSARTAN-HYDROCHLOROTHIAZIDE 155 132 39 38
FLUTICASONE PROPIONATE 154 114 41 40
TORSEMIDE 147 125 42 137
PLAVIX 147 138 42 49
MIRTAZAPINE 135 130 44 56
PREDNISONE 133 103 45 42
ATENOLOL 129 98 46 24
LOVASTATIN 128 123 47 41
BENAZEPRIL HCL 123 109 48 61
MELOXICAM 121 78 49 14
BISOPROLOL-HYDROCHLOROTHIAZIDE 120 60 50 101
LOSARTAN POTASSIUM 119 111 51 25
METFORMIN HCL ER 119 62 51 44
TRIAMTERENE-HYDROCHLOROTHIAZID 116 93 53 194
AMLODIPINE BESYLATE-BENAZEPRIL 115 70 54 59
CIPROFLOXACIN HCL 115 94 54 46
GEMFIBROZIL 113 101 56 105
PANTOPRAZOLE SODIUM 111 68 57 28
AMITRIPTYLINE HCL 110 76 R 58 45
LANTUS 109 108 59 68
POLYETHYLENE GLYCOL 3350 107 101 60 69
RAMIPRIL 101 79 61 77
ROPINIROLE HCL 99 63 62 82
METHADONE HCL 98 15 S2 63 161
DOXYCYCLINE HYCLATE 98 71 63 97
NAMENDA 98 98 63 43
NABUMETONE 96 62 66 169
DIGOXIN 92 89 67 52
ADVAIR DISKUS 90 61 68 65
ALENDRONATE SODIUM 86 75 69 57
JANUMET 86 71 69 195
HYDRALAZINE HCL 86 82 69 74
LEVOCETIRIZINE DIHYDROCHLORIDE 85 68 72 187
MECLIZINE HCL 85 80 72 80
PROMETHAZINE HCL 85 18 R 72 54
DIOVAN 84 72 75 67
AZITHROMYCIN 84 64 75 36
NIFEDIPINE ER 81 73 77 130
SYNTHROID 80 57 78 91
BYSTOLIC 80 58 78 126
FLUCONAZOLE 79 50 80 102
PROAIR HFA 79 60 80 50
SINGULAIR 77 36 82 84
CLOTRIMAZOLE-BETAMETHASONE 77 75 82 173
DIOVAN HCT 74 60 84 96
LIPITOR 74 69 84 170
GLIPIZIDE ER 73 51 86 106
EVISTA 72 51 87 168
CLONIDINE HCL 71 56 88 27
METOCLOPRAMIDE HCL 68 49 89 99
NIFEDICAL XL 68 46 89 232
AMIODARONE HCL 68 68 89 178
RISPERIDONE 68 60 89 87
ISOSORBIDE MONONITRATE ER 68 64 89 71
QUETIAPINE FUMARATE 67 61 94 75
TAMSULOSIN HCL 66 43 95 33
KLOR-CON M20 66 41 95 66
VENTOLIN HFA 63 26 97 83
PREMARIN 62 17 R 98 109
ISOSORBIDE DINITRATE 62 62 98 224
PRAMIPEXOLE DIHYDROCHLORIDE 61 43 100 147
SULFAMETHOXAZOLE-TRIMETHOPRIM 61 40 100 70
CYCLOBENZAPRINE HCL 60 24 R 102 39
QUINAPRIL HCL 59 56 103 117
LEVOXYL 59 59 103 323
MUPIROCIN 59 39 103 140
ESCITALOPRAM OXALATE 58 40 106 60
INSULIN SYRINGE 57 57 107 93
CELEBREX 57 38 107 98
VENLAFAXINE HCL ER 56 34 109 124
DILTIAZEM ER 55 46 110 146
TRIAMCINOLONE ACETONIDE 54 44 111 159
SYMBICORT 53 32 112 149
PHENYTOIN SODIUM EXTENDED 53 44 112 115
BUSPIRONE HCL 53 30 112 110
IPRATROPIUM BROMIDE 53 53 112 203
SPIRIVA 52 39 116 64
AMOX TR-POTASSIUM CLAVULANATE 52 37 116 125
FENTANYL 51 28 S2 118 100
MONTELUKAST SODIUM 51 21 118 132
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.